961 related articles for article (PubMed ID: 15730937)
21. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas.
Shibata C; Kobari M; Tsuchiya T; Arai K; Anzai R; Takahashi M; Uzuki M; Sawai T; Yamazaki T
World J Surg; 2001 Aug; 25(8):1002-5. PubMed ID: 11571964
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma.
Shimada K; Sano T; Sakamoto Y; Kosuge T
Ann Surg Oncol; 2006 Dec; 13(12):1569-78. PubMed ID: 17009145
[TBL] [Abstract][Full Text] [Related]
23. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer.
Tashiro S; Uchino R; Hiraoka T; Tsuji T; Kawamoto S; Saitoh N; Yamasaki K; Miyauchi Y
Surgery; 1991 Apr; 109(4):481-7. PubMed ID: 1848949
[TBL] [Abstract][Full Text] [Related]
24. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
25. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
[TBL] [Abstract][Full Text] [Related]
27. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
28. Managing unsuspected tumour invasion of the superior mesenteric-portal vein during surgery for pancreatic head cancer. A case report.
Casadei R; D'Ambra M; Freyrie A; Monari F; Alagna V; Ricci C; Minni F
JOP; 2009 Jul; 10(4):448-50. PubMed ID: 19581755
[TBL] [Abstract][Full Text] [Related]
29. Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection?
Okada K; Kawai M; Tani M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Surgery; 2013 Mar; 153(3):365-72. PubMed ID: 23046987
[TBL] [Abstract][Full Text] [Related]
30. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
Storkholm JH; Hansen CP
Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
[TBL] [Abstract][Full Text] [Related]
32. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection.
Jain S; Sacchi M; Vrachnos P; Lygidakis NJ
Hepatogastroenterology; 2005; 52(65):1596-600. PubMed ID: 16201124
[TBL] [Abstract][Full Text] [Related]
35. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.
Kato K; Yamada S; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
Pancreas; 2009 Aug; 38(6):605-12. PubMed ID: 19629002
[TBL] [Abstract][Full Text] [Related]
37. Safety of portal vein resection using centrifugal pump-assisted venous bypass between the superior mesenteric vein and the umbilical vein.
Suzuki Y; Yoshida I; Ku Y; Fujino Y; Tanioka Y; Fukumoto T; Iwasaki T; Tominaga M; Kuroda Y
Hepatogastroenterology; 2004; 51(58):1183-6. PubMed ID: 15239274
[TBL] [Abstract][Full Text] [Related]
38. Portal vein resection in pancreatic head carcinoma. Part 1: Technical considerations.
Tuech JJ; Pessaux P; Arnaud JP
Hepatogastroenterology; 2001; 48(39):884-7. PubMed ID: 11462948
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
